Xtandi, also known by its generic name enzalutamide, is a prescription medication primarily indicated for the treatment of advanced prostate cancer. This type of cancer often develops resistance to conventional hormone therapy, necessitating alternative approaches.

Zidovudine, widely recognized in the medical community, is a prominent member of the nucleoside reverse transcriptase inhibitors (NRTIs) family. These inhibitors play an indispensable role in the world of antiretroviral therapy. What makes NRTIs, and particularly Zidovudine, so effective is their strategic targeting and interference with a key process the HIV relies upon: the replication of its genetic material.

Zolmitriptan is prescribed to alleviate the symptoms associated with migraine headaches, which are characterized by severe throbbing head pain, often accompanied by nausea and heightened sensitivity to sound and light. This medication falls under the category of selective serotonin receptor agonists. Its mechanism of action involves the constriction of blood vessels in the brain, interrupting the transmission of pain signals to the brain, and inhibiting the release of specific natural substances responsible for causing pain, nausea, and other migraine symptoms. It’s important to note that Zolmitriptan does not serve as a preventive measure for migraine attacks or a means to reduce the frequency of headaches.